HCV Testing & Linkage to Care – Free Webinar

Thursday, October 26, 2017 at 2:00 pm Eastern / 11:00 am Pacific


Thursday, October 26, 2017 at 2:00 PM Eastern / 11:00 AM Pacific

HCV Testing & Linkage to Care Live Webinar

Harm Reduction Coalition

PRIME

Join Harm Reduction Coalition and PRIME Education, LLC for a live webinar titled HCV Testing & Linkage to Care Through the Lens of Substance Use Disorder Clinics.

This unique webinar highlights key findings from a recent educational series to train counselors, clinicians, and other healthcare providers working in substance use disorder clinics to provide sustainable education to their patients on HCV risks, testing, and harm reduction. Expert faculty will share practical insights and results for increasing HCV awareness and knowledge among persons with substance use disorders, and strategies for strengthening testing and linkage to care.

Faculty

Anthony Martinez, MD, AAHIVS
Associate Clinical Professor of Medicine
University of Buffalo
Medical Director, Hepatology
Erie County Medical Center
Attending Physician
Buffalo General Medical Center
Buffalo, NY

Daniel Raymond
Deputy Director of Planning and Policy
Harm Reduction Coalition
New York, NY
Accreditation

1.0 hour of ACCME, APA, ACPE, ANCC, and CCMC credit for Psychologists, Physicians, NPs, PAs, Nurses, and Case Managers.
Agenda
  1. Understanding Barriers to HCV Linkage to Care
  2. Key Findings from an HCV Educational Initiative in Substance Use Disorder Clinics
  3. Evidence-Based Strategies for Promoting HCV Screening and Testing
  4. Evidence-Based Strategies for Harm Reduction
Learning Objectives
  • Evaluate patients with, or at risk of, HCV infection in order to make appropriate referrals
    to specialists for screening, diagnosis, treatment, or follow-up
  • Apply evidence-based strategies for supporting persons with injection drug use in harm reduction and adhering to potential HCV treatment and monitoring regimens
  • Summarize key efficacy/safety data on new and emerging direct-acting antiviral therapies
    for HCV
  • Integrate patient-centered HCV education into substance use/addiction center visits
    and programs
Register for this webinar


There is no fee for this activity as it is sponsored by PRIME Education, LLC
through educational grants from AbbVie, Inc. and Gilead Sciences, Inc.

 

Designed & Developed by Firefly Partners